Lipoxin A4 (LXA4) as a Potential Drug for Diabetic Retinopathy. [PDF]
Das UN.
europepmc +1 more source
Immunometabolic reprogramming in diabetic osteomyelitis: from mechanisms to therapeutics. [PDF]
Zhang H +6 more
europepmc +1 more source
Cytokine release syndrome and CAR T Cell therapy: Modulating the intensity of the inflammatory response and resolution within the tumor microenvironment. [PDF]
Driscoll DF, Bistrian BR.
europepmc +1 more source
EPA, DHA, and resolvin effects on cancer risk: The underexplored mechanisms. [PDF]
Kiyasu Y +4 more
europepmc +1 more source
Lipid-mediated resolution of inflammation and survival in amyotrophic lateral sclerosis. [PDF]
Yildiz O +11 more
europepmc +1 more source
Deciphering the Potential Role of Specialized Pro-Resolving Mediators in Obesity-Associated Metabolic Disorders. [PDF]
Kim N, Shin HY.
europepmc +1 more source
Leukotriene B4 receptor 1 (BLT1) activation by leukotriene B4 (LTB<sub>4</sub>) and E resolvins (RvE1 and RvE2). [PDF]
Nunes VS +3 more
europepmc +1 more source
Diabetic Wound Vasculopathy and Neuropathy: Spotlight on Wound Lipid Signaling. [PDF]
Bhamidipati T +11 more
europepmc +1 more source
Narrative Review of Chronic Inflammation in Uterine Myoma: Lack of Specialized Pro-Resolving Lipid Mediators (SPMs) and Vitamin D as a Potential Reason for the Development of Uterine Fibroids. [PDF]
Regidor PA +5 more
europepmc +1 more source
Fish Oil-Containing Injectable Lipid Emulsions in Parenteral Nutrition: Immunomodulation and Clinical Outcomes in Critically Ill Patients-Narrative Review. [PDF]
Kęska M +4 more
europepmc +1 more source

